About Conference
West Coast Optometric Glaucoma Symposium 2024 will be held as an in-person event on December 6-7, 2024 in Carlsbad, CA. We invite you to join us for a two-day event which will include case presentations, Q&A sessions, and literature analysis. We are excited to highlight critical themes, new developments, and treatments in glaucoma. Experts will share the latest data, research, and practical knowledge.
Highlights
The esteemed faculty will dive deep into all aspects of glaucoma and weigh in on treatments that directly combat glaucoma in your patients. West Coast Optometric Glaucoma Symposium 2024 will be in succession with Retina Update 2024. We encourage you to participate in both symposia.
Find on Map
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
Advances in "next generation" photoactive cancer therapy
2.
Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL
3.
The American College of Physicians updated its recommendations for colorectal cancer screening.
4.
Optimizing Sequencing of BCMA-Directed Therapies in Myeloma
5.
According to a study, patients with ovarian cancer who undergo aggressive surgery have a 70% lower chance of dying.
1.
Quality of Life Using Precision Functional Recovery After Organ-Preserving Interventions
2.
Cancer Memory: A Persistent Threat to Tumor Recurrence and Metastasis
3.
Neoadjuvant Abraxane Chemotherapy Combined with Neutrophil Cytopharmaceuticals and Radiotherapy
4.
Modern Developments in Oncology for Specialists
5.
Can We Repurpose BV-CHP for Better Outcomes in Peripheral T-Cell Lymphoma?
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
1.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
2.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
3.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
4.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
5.
Navigating the Complexities of Ph Negative ALL - Part XII
Recommended News For You
1.
Citing a cancer risk, the EPA sets a new limit on medical sterilization chemicals.
2.
Oleanolic acid from grapes may increase chemotherapy effectiveness
3.
An ancient signaling pathway and 20 years of research offer hope for rare cancer
4.
A pilot study investigates a novel strategy for lowering anxiety and enhancing post-stem cell transplant quality of life.
5.
Frontline Mosunetuzumab Shows High Response Rates in Follicular Lymphoma
Conferences That Might Interest You
Recommended Articles For You
1.
Biomimetic Nanovesicles Target Senescent-Escape Cancer Stem Cells in Breast Cancer
2.
Targeting the Tumor Microenvironment: Next-Generation Strategies for Immuno-Oncology Success
3.
Engineered Platelet-Producing Tissue for Hematologic Applications
4.
The Future of Cancer Care: Genetics, Support Systems, and Emerging Therapies
5.
Innovative Pathways in Oncology Across Clinical Settings
Boost Your Knowledge With These Quizzes
1.
Quiz on Zenocutuzumab-zbco: Transforming Oncology Through Precision Therapy
2.
Quiz on Managing Overactive Bladder (OAB): Are You Up-to-Date on Effective Treatments?
3.
Quiz On Azithromycin Usage
4.
Quiz on Exploring Bronchiectasis: Causes, Symptoms, Diagnosis, and Treatment Options
5.
Quiz on Pediatric Speech Therapy
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge